4.8 Article

Human CHN1 mutations hyperactivate α2-chimaerin and cause Duane's retraction syndrome

Journal

SCIENCE
Volume 321, Issue 5890, Pages 839-843

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1156121

Keywords

-

Funding

  1. Medical Research Council [G9900989, G9900837] Funding Source: researchfish
  2. Howard Hughes Medical Institute Funding Source: Medline
  3. Medical Research Council [G9900837, G9900989] Funding Source: Medline
  4. NEI NIH HHS [R01 EY015298-02, R01 EY015298-04, R01 EY015298-01, R01 EY015298-05, R01 EY015298-03, R01 EY015298] Funding Source: Medline
  5. MRC [G9900989, G9900837] Funding Source: UKRI

Ask authors/readers for more resources

Duane's retraction syndrome (DRS) is a complex congenital eye movement disorder caused by aberrant innervation of the extraocular muscles by axons of brainstem motor neurons. Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes alpha 2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein previously implicated in the pathfinding of corticospinal axons in mice. We found that these are gain-of-function mutations that increase alpha 2-chimaerin RacGAP activity in vitro. Several of the mutations appeared to enhance alpha 2-chimaerin translocation to the cell membrane or enhance its ability to self-associate. Expression of mutant alpha 2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles. We conclude that alpha 2-chimaerin has a critical developmental function in ocular motor axon pathfinding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available